Release Date: 25/09/18 08:23 Summary: Consolidation/Split - MUS Price Sensitive: No Download Document 52.58KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%